Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204964402> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W3204964402 endingPage "436" @default.
- W3204964402 startingPage "433" @default.
- W3204964402 abstract "As the COVID-19 pandemic continues, case reports have been published where patients with severe asthma using biological agents survived with a mild course of illness and encouraged the continuation of biological therapies in patients with severe asthma. However, contrary to previous information, a more severe course of COVID-19 has recently been reported in severe asthmatics using biological therapy compared to the general population. To evaluate the COVID-19 rate and disease severity in severe asthmatics using biological agents. A retrospective study was conducted in patients with severe asthma treated with biological agents. Data concerning whether the subjects had contracted COVID-19 and the severity of the disease were evaluated. Eihgty-four severe asthmatics using biological agents (omalizumab or mepolizumab) aged 48.3 ± 10.6 years (mean ± standard deviation) with female/male ratio: 53 (63.1%)/31 (36.9%) were included in the study. Among participants 13 (15.5%) had contracted COVID-19. The course of COVID-19 was mild in five (38.5%) and moderate in eight patients (61.5%), while none of the patients had a severe course of COVID-19. Mechanical ventilation or intensive care follow-up was not required in any of the six patients (46.2%) who were treated as inpatients. All participants survived COVID-19 in full recovery and no deaths occurred in the cases. A higher rate of COVID-19 was found in patients with severe asthma using biologics compared to those reported in previous reports. However, all patients with COVID-19 have a mild to moderate disease course." @default.
- W3204964402 created "2021-10-11" @default.
- W3204964402 creator A5003771916 @default.
- W3204964402 creator A5027603408 @default.
- W3204964402 creator A5028745011 @default.
- W3204964402 creator A5034526928 @default.
- W3204964402 creator A5062458328 @default.
- W3204964402 creator A5062958759 @default.
- W3204964402 creator A5063218347 @default.
- W3204964402 creator A5063954079 @default.
- W3204964402 creator A5077346784 @default.
- W3204964402 date "2021-09-22" @default.
- W3204964402 modified "2023-10-01" @default.
- W3204964402 title "COVID-19 in patients with severe asthma using biological agents" @default.
- W3204964402 doi "https://doi.org/10.5578/tt.20219721" @default.
- W3204964402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34581170" @default.
- W3204964402 hasPublicationYear "2021" @default.
- W3204964402 type Work @default.
- W3204964402 sameAs 3204964402 @default.
- W3204964402 citedByCount "7" @default.
- W3204964402 countsByYear W32049644022021 @default.
- W3204964402 countsByYear W32049644022022 @default.
- W3204964402 countsByYear W32049644022023 @default.
- W3204964402 crossrefType "journal-article" @default.
- W3204964402 hasAuthorship W3204964402A5003771916 @default.
- W3204964402 hasAuthorship W3204964402A5027603408 @default.
- W3204964402 hasAuthorship W3204964402A5028745011 @default.
- W3204964402 hasAuthorship W3204964402A5034526928 @default.
- W3204964402 hasAuthorship W3204964402A5062458328 @default.
- W3204964402 hasAuthorship W3204964402A5062958759 @default.
- W3204964402 hasAuthorship W3204964402A5063218347 @default.
- W3204964402 hasAuthorship W3204964402A5063954079 @default.
- W3204964402 hasAuthorship W3204964402A5077346784 @default.
- W3204964402 hasBestOaLocation W32049644021 @default.
- W3204964402 hasConcept C116675565 @default.
- W3204964402 hasConcept C126322002 @default.
- W3204964402 hasConcept C159047783 @default.
- W3204964402 hasConcept C177713679 @default.
- W3204964402 hasConcept C203014093 @default.
- W3204964402 hasConcept C2776042228 @default.
- W3204964402 hasConcept C2778137277 @default.
- W3204964402 hasConcept C2779134260 @default.
- W3204964402 hasConcept C3006700255 @default.
- W3204964402 hasConcept C3007834351 @default.
- W3204964402 hasConcept C3008058167 @default.
- W3204964402 hasConcept C524204448 @default.
- W3204964402 hasConcept C71924100 @default.
- W3204964402 hasConcept C89623803 @default.
- W3204964402 hasConceptScore W3204964402C116675565 @default.
- W3204964402 hasConceptScore W3204964402C126322002 @default.
- W3204964402 hasConceptScore W3204964402C159047783 @default.
- W3204964402 hasConceptScore W3204964402C177713679 @default.
- W3204964402 hasConceptScore W3204964402C203014093 @default.
- W3204964402 hasConceptScore W3204964402C2776042228 @default.
- W3204964402 hasConceptScore W3204964402C2778137277 @default.
- W3204964402 hasConceptScore W3204964402C2779134260 @default.
- W3204964402 hasConceptScore W3204964402C3006700255 @default.
- W3204964402 hasConceptScore W3204964402C3007834351 @default.
- W3204964402 hasConceptScore W3204964402C3008058167 @default.
- W3204964402 hasConceptScore W3204964402C524204448 @default.
- W3204964402 hasConceptScore W3204964402C71924100 @default.
- W3204964402 hasConceptScore W3204964402C89623803 @default.
- W3204964402 hasIssue "3" @default.
- W3204964402 hasLocation W32049644021 @default.
- W3204964402 hasOpenAccess W3204964402 @default.
- W3204964402 hasPrimaryLocation W32049644021 @default.
- W3204964402 hasRelatedWork W3017171836 @default.
- W3204964402 hasRelatedWork W3036899716 @default.
- W3204964402 hasRelatedWork W3040137343 @default.
- W3204964402 hasRelatedWork W3042427510 @default.
- W3204964402 hasRelatedWork W3045573749 @default.
- W3204964402 hasRelatedWork W3127941442 @default.
- W3204964402 hasRelatedWork W3199363150 @default.
- W3204964402 hasRelatedWork W4280491013 @default.
- W3204964402 hasRelatedWork W4308017287 @default.
- W3204964402 hasRelatedWork W3107152225 @default.
- W3204964402 hasVolume "69" @default.
- W3204964402 isParatext "false" @default.
- W3204964402 isRetracted "false" @default.
- W3204964402 magId "3204964402" @default.
- W3204964402 workType "article" @default.